The global fluorescent immunoassay market was valued at US$ 2,578.66 million in 2021 and is projected to reach US$ 3,778.78 million by 2028; it is expected to grow at a CAGR of 5.6% from 2021 to 2028.
The growth of the global fluorescent immunoassay market is mainly attributed to factors such as growing prevalence of chronic diseases worldwide and increasing demand for cell therapies. However, the global fluorescent immunoassay market is likely to get impacted by the disadvantages of fluorescent immunoassays during the forecast period.Fluorescent immunoassays are simply a different type of immunoassay. The critical variable is the biochemical technique used to detect the binding of the "detector" antibody and the analyte molecule. Fluorescent immunoassay is a sensitive technique that can measure many compounds, including drugs, hormones, and proteins; identify antibodies; and quantify antigens such as viral particles and possibly bacteria. The fluorescence detection system includes higher sensitivity detection of the analyte, simplified reagents, and simpler assay designs. Several breakthroughs have been made in recent years that have enabled a fluorescence-based immunoassay system at the point of care. Several technical improvements have recently occurred that have allowed a susceptible immunoassay system to implement. These include the availability of narrow-wavelength, low-cost light sources, newer, more stable fluorophores with extensive Stokes shifts, stable solid-state light detectors, and microprocessors to process and analyze the data from each test. When a fluorescence detection system is connected to a lateral flow assay and combined with a powerful yet inexpensive analyzer, the result is improved assay performance.
Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been feeling the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time PCR tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Fluorescent immunoassay is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with red reagent cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures. Fluorescent immunoassay is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.
The spread of COVID-19 severely affected medical systems in the region. Many commercially available tests for detecting SARS-CoV-2-specific antigens have recently been developed. The identification of COVID-19 antibodies in people as an alternative diagnostic method has recently received a lot of attention. To identify SARS-CoV-2, several clinics have used quick colloidal gold, enzyme-linked immunosorbent assay (ELISA), and chemiluminescence assays. These approaches, however, have flaws in terms of accuracy and sensitivity, with a large frequency of COVID-19 false positive and false negative reports. The STANDARD F COVID-19 Ag fluorescence immunoassay (FIA) kit is also available, which uses a fluorescent immunoassay to detect specific nucleoprotein antigens to SARS-CoV-2 in the human nasopharynx. Thus, rising incidence of coronavirus cases and growing government approvals for test kits are responsible for the growth of the global fluorescent immunoassay market.
The COVID-19 pandemic has become the most significant challenge across the world. This challenge was frightening, especially in developing countries across the globe, as it reduced imports due to disruptions in global trade. To date, no definitive treatment against COVID-19 has been established. Hence, the lack of definitive therapy offers significant opportunities for the global fluorescent immunoassay market. In the long run, the fluorescent immunoassay market would have significant growth prospects as many market players had received emergency use authorization for their newly developed tests. In May 2020, ERBA Diagnostics Mannheim GmbH (Germany) launched its immunoassay-based kit - ErbaLisa COVID-19 ELISA kits - to detect IgG and IgM antibodies against SARS-CoV-2. In addition, researchers developed portable devices, reagents, and standards suitable for home use. Therefore, all such developments would add up to the proliferating future demand for fluorescent immunoassays.
Based on product type, the global fluorescent immunoassay market is segmented into ELISA, rapid lateral flow immunoassay, and others. In 2021, the ELISA segment accounted for the largest share of the market. ELISA is a plate-based test technique for detecting and measuring soluble molecules such as peptides, proteins, antibodies, and hormones. The growth of this segment is attributed to the significant use of immunoassay tests to diagnose cancer, infectious illnesses, and other chronic problems. The same segment is likely to register the highest CAGR in the global fluorescent immunoassay market during the forecast period.
In terms of application, the global fluorescent immunoassay market is segmented into infectious diseases, oncology, cardiovascular diseases, and others. The infectious diseases segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.
The global fluorescent immunoassay market, based on end user, is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. The hospitals & clinics segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR of 6.6% in the market during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention, National Center for Biotechnology Information, National Institute of Cancer Prevention and Research (NICPR), Public Health Agency of Canada, and Organization for Economic Co-operation and Development (OECD) are some of the major primary and secondary sources referred for preparing this report.
The growth of the global fluorescent immunoassay market is mainly attributed to factors such as growing prevalence of chronic diseases worldwide and increasing demand for cell therapies. However, the global fluorescent immunoassay market is likely to get impacted by the disadvantages of fluorescent immunoassays during the forecast period.Fluorescent immunoassays are simply a different type of immunoassay. The critical variable is the biochemical technique used to detect the binding of the "detector" antibody and the analyte molecule. Fluorescent immunoassay is a sensitive technique that can measure many compounds, including drugs, hormones, and proteins; identify antibodies; and quantify antigens such as viral particles and possibly bacteria. The fluorescence detection system includes higher sensitivity detection of the analyte, simplified reagents, and simpler assay designs. Several breakthroughs have been made in recent years that have enabled a fluorescence-based immunoassay system at the point of care. Several technical improvements have recently occurred that have allowed a susceptible immunoassay system to implement. These include the availability of narrow-wavelength, low-cost light sources, newer, more stable fluorophores with extensive Stokes shifts, stable solid-state light detectors, and microprocessors to process and analyze the data from each test. When a fluorescence detection system is connected to a lateral flow assay and combined with a powerful yet inexpensive analyzer, the result is improved assay performance.
Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been feeling the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time PCR tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Fluorescent immunoassay is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with red reagent cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures. Fluorescent immunoassay is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.
The spread of COVID-19 severely affected medical systems in the region. Many commercially available tests for detecting SARS-CoV-2-specific antigens have recently been developed. The identification of COVID-19 antibodies in people as an alternative diagnostic method has recently received a lot of attention. To identify SARS-CoV-2, several clinics have used quick colloidal gold, enzyme-linked immunosorbent assay (ELISA), and chemiluminescence assays. These approaches, however, have flaws in terms of accuracy and sensitivity, with a large frequency of COVID-19 false positive and false negative reports. The STANDARD F COVID-19 Ag fluorescence immunoassay (FIA) kit is also available, which uses a fluorescent immunoassay to detect specific nucleoprotein antigens to SARS-CoV-2 in the human nasopharynx. Thus, rising incidence of coronavirus cases and growing government approvals for test kits are responsible for the growth of the global fluorescent immunoassay market.
The COVID-19 pandemic has become the most significant challenge across the world. This challenge was frightening, especially in developing countries across the globe, as it reduced imports due to disruptions in global trade. To date, no definitive treatment against COVID-19 has been established. Hence, the lack of definitive therapy offers significant opportunities for the global fluorescent immunoassay market. In the long run, the fluorescent immunoassay market would have significant growth prospects as many market players had received emergency use authorization for their newly developed tests. In May 2020, ERBA Diagnostics Mannheim GmbH (Germany) launched its immunoassay-based kit - ErbaLisa COVID-19 ELISA kits - to detect IgG and IgM antibodies against SARS-CoV-2. In addition, researchers developed portable devices, reagents, and standards suitable for home use. Therefore, all such developments would add up to the proliferating future demand for fluorescent immunoassays.
Based on product type, the global fluorescent immunoassay market is segmented into ELISA, rapid lateral flow immunoassay, and others. In 2021, the ELISA segment accounted for the largest share of the market. ELISA is a plate-based test technique for detecting and measuring soluble molecules such as peptides, proteins, antibodies, and hormones. The growth of this segment is attributed to the significant use of immunoassay tests to diagnose cancer, infectious illnesses, and other chronic problems. The same segment is likely to register the highest CAGR in the global fluorescent immunoassay market during the forecast period.
In terms of application, the global fluorescent immunoassay market is segmented into infectious diseases, oncology, cardiovascular diseases, and others. The infectious diseases segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.
The global fluorescent immunoassay market, based on end user, is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. The hospitals & clinics segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR of 6.6% in the market during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention, National Center for Biotechnology Information, National Institute of Cancer Prevention and Research (NICPR), Public Health Agency of Canada, and Organization for Economic Co-operation and Development (OECD) are some of the major primary and secondary sources referred for preparing this report.
Table of Contents
1. Introduction1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Fluorescent Immunoassay Market - By Product Type
1.3.2 Fluorescent Immunoassay Market - By Application
1.3.3 Fluorescent Immunoassay Market - By End User
1.3.4 Global Fluorescent Immunoassay Market - By Geography
2. Fluorescent Immunoassay Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Fluorescent Immunoassay Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa - PEST Analysis
4.2.5 South & Central America- PEST Analysis
4.3 Expert Opinions
5. Fluorescent Immunoassay Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Chronic Diseases
5.1.2 Increasing Demand for Cell Therapies
5.2 Market Restraints
5.2.1 Disadvantages of Fluorescent Immunoassays
5.3 Market Opportunities
5.3.1 Extensive Usage in Cancer Diagnostics
5.4 Future Trends
5.4.1 Increase in Development of Fluorescent Dyes and Instruments
5.5 Impact Analysis
6. Fluorescent Immunoassay Market - Global Analysis
6.1 Global Fluorescent Immunoassay Marker Revenue Forecast and Analysis
6.1.1 Global Fluorescent Immunoassay Market, By Geography - Forecast And Analysis
6.1.2 Global Fluorescent Immunoassay Market - Market Potential Analysis, By Region
6.1.3 Market Share Analysis of Fluorescent Immunoassay Market
6.2 Company Analysis
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance Of Key Players
6.2.4.1 F. Hoffman-La Roche Ltd.
6.2.4.2 Thermo Fisher Scientific Inc.
7. Fluorescent Immunoassay Market Analysis and Forecasts to 2028 Product Type
7.1 Overview
7.2 Global Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)
7.3 ELISA
7.3.1 Overview
7.3.2 ELISA: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.4 Rapid Lateral Flow Immunoassay
7.4.1 Overview
7.4.2 Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8. Fluorescent Immunoassay Market Analysis - By Application
8.1 Overview
8.2 Global Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.4 Oncology
8.4.1 Overview
8.4.2 Oncology: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9. Fluorescent Immunoassay Market - By End User
9.1 Overview
9.2 Global Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.5 Pharmaceutical & Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.6 Academic & Research Institutes
9.6.1 Overview
9.6.2 Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
10. Fluorescent Immunoassay Market Analysis and Forecasts To 2028 Geographical Analysis
10.1 North America: Fluorescent Immunoassay Market
10.1.1 Overview
10.1.2 North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.3 North America: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.4 North America: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.5 North America: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.6 North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
10.1.6.1 US: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.6.1.3 US: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.6.1.5 US: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.6.2.3 Canada: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.6.2.5 Canada: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.6.3.3 Mexico: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.6.3.5 Mexico: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.2 Europe: Fluorescent Immunoassay Market
10.2.1 Overview
10.2.2 Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.2.1.1 Europe: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.2.2.1.2 Europe: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.2.2.1.3 Europe: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
10.2.3.1 Germany: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.2.3.1.1 Overview
10.2.3.1.2 Germany: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.1.3 Germany: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.2.3.1.4 Germany: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.2.3.1.5 Germany: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.2.3.2 UK: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.2.3.2.1 Overview
10.2.3.2.2 UK: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.2.3 UK: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.2.3.2.4 UK: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.2.3.2.5 UK: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.2.3.3 France: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.2.3.3.1 Overview
10.2.3.3.2 France: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.3.3 France: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.2.3.3.4 France: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.2.3.3.5 France: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.2.3.4 Italy: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.2.3.4.1 Overview
10.2.3.4.2 Italy: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.4.3 Italy: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.2.3.4.4 Italy: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.2.3.4.5 Italy: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.2.3.5 Spain: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.2.3.5.1 Overview
10.2.3.5.2 Spain: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.5.3 Spain: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.2.3.5.4 Spain: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.2.3.5.5 Spain: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.2.3.6 Rest of Europe: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.2.3.6.1 Overview
10.2.3.6.2 Rest of Europe: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.6.3 Rest of Europe: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.2.3.6.4 Rest of Europe: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.2.3.6.5 Rest of Europe: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.3 Asia Pacific: Fluorescent Immunoassay Market
10.3.1 Overview
10.3.2 Asia Pacific: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia-Pacific: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.3.4 Asia-Pacific: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.3.5 Asia-Pacific: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.3.6 Asia Pacific: Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3 China: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.3.6.1.4 China: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.3.6.2 Japan: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3 Japan: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.3.6.2.4 Japan: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.3.6.3 India: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 India: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3 India: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.3.6.3.4 India: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.3.6.4 South Korea: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 South Korea: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 South Korea: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.3.6.4.3 South Korea: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.3.6.4.4 South Korea: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.3.6.5 Australia: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 Australia: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 Australia: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.3.6.5.3 Australia: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.3.6.5.4 Australia: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.4 Middle East & Africa: Fluorescent Immunoassay Market
10.4.1 Overview
10.4.2 Middle East & Africa: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East & Africa Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.4.4 Middle East & Africa Fluorescent Immunoassay Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.4.5 Middle East & Africa Fluorescent Immunoassay Market, by End User- Revenue and Forecast to 2028 (USD Million)
10.4.6 Middle East & Africa Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)
10.4.6.1 Saudi Arabia: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Saudi Arabia: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.1.2 Saudi Arabia Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3 Saudi Arabia Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.4.6.1.4 Saudi Arabia Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.4.6.2 UAE: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 UAE: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.2.2 UAE: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3 UAE: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.4.6.2.4 UAE: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.4.6.3 South Africa: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.3.1 South Africa: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2 South Africa Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3 South Africa Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.4.6.3.4 South Africa Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.4.6.4 Rest of Middle East and Africa: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.4.1 Rest of Middle East and Africa: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.4.2 Rest of Middle East & Africa Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.4.6.4.3 Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.4.6.4.4 Rest of Middle East & Africa: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.5 South and Central America: Fluorescent Immunoassay Market
10.5.1 Overview
10.5.2 South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.2.1.1 South and Central America: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.5.2.1.2 South and Central America: Fluorescent Immunoassay Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.5.2.1.3 South and Central America: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
10.5.3.1 Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.3.1.1 Overview
10.5.3.1.2 Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.3.1.3 Brazil: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.5.3.1.4 Brazil: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.5.3.1.5 Brazil: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million
10.5.3.2 Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.3.2.1 Overview
10.5.3.2.2 Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.3.2.3 Argentina: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.5.3.2.4 Argentina: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.5.3.3 Rest of South and Central America: Fluorescent Immunoassay Market- Revenue and Forecast to 2028 (USD Mn)
10.5.3.3.1 Overview
10.5.3.3.2 Rest of South and Central America: Fluorescent Immunoassay Market- Revenue and Forecast to 2028 (USD Mn)
10.5.3.3.3 Rest of South and Central America: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.5.3.3.4 Rest of South and Central America: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.5.3.3.5 Rest of South and Central America: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Fluorescent Immunoassay Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Fluorescent Immunoassay Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Abbott
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BD
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Danaher
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sysmex Corporation
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Siemens AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Ortho Clinical Diagnostics Holdings plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Quidel Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Companies Mentioned
- Thermo Fisher Scientific
- Abbott Laboratories
- Ortho Clinical Diagnostics
- BD
- F. Hoffmann La Roche
- Danaher
- bioMérieux SA
- Siemens AG
- Sysmex
- Quidel Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | May 2022 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( $ | $ 2578.66 million |
| Forecasted Market Value ( $ | $ 3778.78 million |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
